Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Insulin increases sensory nerve density and reflex bronchoconstriction in obese mice
Gina N. Calco, Jessica N. Maung, David B. Jacoby, Allison D. Fryer, Zhenying Nie
Gina N. Calco, Jessica N. Maung, David B. Jacoby, Allison D. Fryer, Zhenying Nie
View: Text | PDF
Research Article Metabolism Pulmonology

Insulin increases sensory nerve density and reflex bronchoconstriction in obese mice

  • Text
  • PDF
Abstract

Obesity-induced asthma responds poorly to all current pharmacological interventions, including steroids, suggesting that classic, eosinophilic inflammation is not a mechanism. Since insulin resistance and hyperinsulinemia are common in obese individuals and associated with increased risk of asthma, we used diet-induced obese mice to study how insulin induces airway hyperreactivity. Inhaled 5-HT or methacholine induced dose-dependent bronchoconstriction that was significantly potentiated in obese mice. Cutting the vagus nerves eliminated bronchoconstriction in both obese and nonobese animals, indicating that it was mediated by a neural reflex. There was significantly greater density of airway sensory nerves in obese compared with nonobese mice. Deleting insulin receptors on sensory nerves prevented the increase in sensory nerve density and prevented airway hyperreactivity in obese mice with hyperinsulinemia. Our data demonstrate that high levels of insulin drives obesity-induced airway hyperreactivity by increasing sensory innervation of the airways. Therefore, pharmacological interventions to control metabolic syndrome and limit reflex-mediated bronchoconstriction may be a more effective approach to reduce asthma exacerbations in obese and patients with asthma.

Authors

Gina N. Calco, Jessica N. Maung, David B. Jacoby, Allison D. Fryer, Zhenying Nie

×

Figure 6

Specific KO of insulin receptor in sensory neurons prevented potentiated reflex bronchoconstriction in mice on a high-fat diet.

Options: View larger image (or click on image) Download as PowerPoint
Specific KO of insulin receptor in sensory neurons prevented potentiated...
(A) Airway resistance was measured in anesthetized and mechanically ventilated sensory insulin receptor–KO (SNIRKO) mice. 5-HT induced dose dependent bronchoconstriction in high-fat diet–fed SNIRKO mice without tamoxifen treatment (filled diamonds). Knocking out insulin receptors on sensory nerves with tamoxifen significantly inhibited 5-HT induced bronchoconstriction resulting from a high fat diet (filled squares). Tamoxifen alone did not inhibit 5-HT induced bronchoconstriction in WT mice on a high fat diet (filled triangles) or inhibit 5-HT induced bronchoconstriction in SNIRKO mice on a normal diet (open squares). (B) Response to 5-HT was eliminated by vagotomy in all mice. (C) Following vagotomy, bronchoconstriction in response to inhaled methacholine (MCh) was similar in SNIRKO mice with and without tamoxifen on a high-fat diet. Each data point represents the mean ± SEM using 2-way repeated-measures ANOVA (n = 6–7). *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts